Intercept Pharmaceuticals

189 articles with Intercept Pharmaceuticals

• Intercept Pharma To Report First Quarter 2016 Financial Results On May 5

  11/3/2016

• Intercept Pharma Announces Ocaliva (Obeticholic Acid) Data In PBC To Be Presented At The 2016 AASLD Annual Meeting

  11/1/2016

• Intercept Pharma To Report Third Quarter 2016 Financial Results On November 3

  10/31/2016

• Intercept Pharma Gains Positive CHMP Opinion for Ocaliva

  10/14/2016

• Gilead Might Avoid Fighting Celgene, But Allergan, Intercept Pharma and Novartis AG Await

  10/4/2016

• Intercept Pharma Files New Drug Submission To Health Canada For Marketing Approval Of Obeticholic Acid For The Treatment Of Patients With Primary Biliary Cholangitis

  9/19/2016

• Intercept Pharma To Present At Upcoming Investor Conferences

  9/2/2016

• Intercept Pharma Release: The New England Journal of Medicine Publishes Results Of Phase III POISE Trial Of Ocaliva (Obeticholic Acid) For The Treatment Of PBC

  8/18/2016

• Intercept Pharma To Report Second Quarter 2016 Financial Results On August 4 And Present At Upcoming Conference

  7/28/2016

• 5 Biotech Stocks on the Brink of Breaking Out

  7/25/2016

• Almac Group's Rapid Launch Services Support U.S. Approval Of Intercept Pharma's First Commercial Orphan Drug Product

  7/21/2016

• Almac Group's Rapid Launch Services Support U.S. Approval Of Intercept Pharma's First Commercial Orphan Drug Product

  7/14/2016

• Intercept Pharma Taps Former Novartis AG Exec to Replace Longtime CFO

  6/10/2016

• Why Intercept Pharma Just Became an Even More Attractive Takeover Target

  6/1/2016

• Intercept Pharma's Liver Drug Wins Accelerated Approval by the FDA

  5/31/2016

• The M&A Rumor Mill Points to Gilead Acquiring Intercept Pharma

  4/28/2016

• FDA Panel Unanimously Backs Speedy Approval of Intercept Pharma's Liver Disease Drug Ocaliva

  4/11/2016

• Adam Feuerstein's Biotech Stock Mailbag: Intercept Pharma, Acadia, Keryx. Galena Biopharma

  4/1/2016

• Three Biotechs Cited as Promising Bets in 2016 With FDA Decisions Pending

  2/22/2016

• AstraZeneca PLC Rumored to Be Interested in Buying Intercept Pharma

  2/12/2016